Smoking and risk of low- and high-grade prostate cancer: Results from the REDUCE study

Clinical Cancer Research

Volumn 20, Issue 20, 2014, Pages 5331-5338

  Ho, Tammy ^a,b   Howard, Lauren E ^a,b   Vidal, Adriana C ^a,b   Gerber, Leah ^a,b   Moreira, Daniel ^c   McKeever, Madeleine ^b   Andriole, Gerald ^d,e   Castro Santamaria, Ramiro ^f   Freedland, Stephen J ^a,b,g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c Northwell Health   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BARNES JEWISH HOSPITAL   (United States)

^f GLAXOSMITHKLINE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUTASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER RISK; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; SMOKING CESSATION; SMOKING HABIT; TRANSRECTAL ULTRASONOGRAPHY; ADVERSE EFFECTS; CLINICAL TRIAL; CONTROLLED STUDY; MULTICENTER STUDY; PATHOLOGY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC NEOPLASMS; RISK; RISK FACTORS; SMOKING;

EID: 84909647571     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2394     Document Type: Article

References (28)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Zu K, Giovannucci E. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 2009;20:1799-810.
3. Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, et al. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology 2007;69:721-5.
4. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev 1999;8:277-82.
5. Lotufo PA, Lee IM, Ajani UA, Hennekens CH, Manson JE. Cigarette smoking and risk of prostate cancer in the physicians' health study (United States). Int J Cancer 2000;87:141-4.
6. Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010;100:693-701.
7. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control 2008;19:25-31.
8. Rohrmann S, Linseisen J, Allen N, Bueno-de-Mesquita HB, Johnsen NF, Tjonneland A, et al. Smoking and the risk of prostate cancer in the European prospective investigation into cancer and nutrition. Br J Cancer 2013;108:708-14.
9. Moreira DM, Antonelli JA, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, et al. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. Urology 2010;76:1218-23.
10. Roberts WW, Platz EA, Walsh PC. Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol 2003;169: 512-6.
11. Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int 2007;99: 564-9.
12. Pickles T, Liu M, Berthelet E, Kim-Sing C, Kwan W, Tyldesley S. The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol 2004;171:1543-6.
13. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192-202.
14. Freedland SJ, Hamilton RJ, Gerber L, Banez LL, Moreira DM, Andriole GL, et al. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis 2013;16:254-259.
15. Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, et al. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer 2014; 120:197-204.
16. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, et al. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ rural health study (United States). Cancer Causes Control 1997;8: 229-38.
17. Coughlin SS, Neaton JD, Sengupta A. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996; 143:1002-1006.
18. Moreira DM, Antonelli JA, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, et al. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. Urology 2010;76:1218-23.
19. Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 2010;34:611-7.
20. Chen TT, Heidelberger C. Quantitative studies on the malignant transformation of mouse prostate cells by carcinogenic hydrocarbons in vitro. Int J Cancer 1969;4:166-78.
21. Daniell HW. A worse prognosis for smokers with prostate cancer. J Urol 1995;154:153-7.
22. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 1987;77:439-44.
23. Smith L, Brinton LA, Spitz MR, Lam TK, Park Y, Hollenbeck AR, et al. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst 2012;104: 778-89.
24. Petrick JL, Gaudet MM, Weissler MC, Funkhouser WK, Olshan AF. Body mass index and risk of head and neck cancer by race: the Carolina head and neck cancer epidemiology study. Ann Epidemiol 2014;24:160-4.
25. Banez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007;298: 2275-80.
26. Joshu CE, Mondul AM, Meinhold CL, Humphreys EB, Han M, Walsh PC, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 2011;103:835-8.
27. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tobacco Control 1997;6: S57-62.
28. Hsing AW, McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr. Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol 1991;133:437-41.